AzTrials
AzTrials

Postoperative Cognitive DysfunctionCardChNeuroMRINCT01622452

Post Cardiac Surgery Neurocognitive Decline: Correlations Between Neuropsychological Tests and Functional MRI Techniques

An observational study of Postoperative Cognitive Dysfunction, run by Fondazione Toscana Gabriele Monasterio.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative cognitive decline (POCD) is a frequent complication after cardiac surgery. It is estimated that 40-70% of all cardiac patients show cognitive dysfunction during the first post-surgical week. Six weeks after surgery, this incidence decreases to 10-40% and the figure remains stable over the long-term. Read more about this study

Who is it for?
Ages 35 to 70 years
Conditions the study is for
Postoperative Cognitive Dysfunction
How many people
50 participants
Where
No sites listed yet
Study dates
Oct 2013to Oct 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing elective valve surgery in Ospedale del Cuore, Fondazione G. Monasterio, Massa, Italy and matching inclusion/exclusion criteria will prospectively enter the study.

Who may be able to join

  • Patients undergoing elective valve surgery in Ospedale del Cuore, Fondazione G. Monasterio, Massa, Italy will prospectively enter the study.

Who cannot join

  • History of head trauma, seizures, stroke, carotid artery stenosis (>70%)
  • History of any major surgery with general anesthesia
  • Preoperative MMSE score less than 23 to exclude patients with dementia and mild cognitive impairment (MCI)
  • Subjects who will be unable to complete the baseline neuropsychological battery due to cognitive impairment, psychiatric disease, substance abuse, blindness, or poor knowledge of Italian language
  • Any major neurological complication after CABG surgery (stroke, seizures, encephalopathy not resolving within few postoperative days)
  • if any contraindications to MRI safety, indicated in local MRI safety protocol

Trial locations and contacts

No sites are listed yet.

Domenico Montanaro, MD contact

+390585493564

domenico.montanaro@ftgm.it

About this study

Official title: Neurocognitive Deficits Related to Cardiac Surgery Intervention With Extracorporeal Circulation. Correlations Between Neuropsychological Tests and Functional MRI Techniques (Spectroscopy, Diffusion and Morphometry)

Postoperative cognitive decline (POCD) is a frequent complication after cardiac surgery. It is estimated that 40-70% of all cardiac patients show cognitive dysfunction during the first post-surgical week. Six weeks after surgery, this incidence decreases to 10-40% and the figure remains stable over the long-term.

The investigators will recruit 50 patients undergoing elective valve surgery and each patient will receive complete evaluation a) preoperative, one week before surgery; b) early postoperative, before hospital discharge; and c) late postoperative, 8 weeks follow up.

The investigators will apply Diffusion Tensor Imaging, 1Proton-Magnetic Resonance Spectroscopy and Morphometry studies with correlation to neuropsychological test battery to evaluate POCD.

Keywords
Postoperative cognitive dysfunction, Cognitive decline, Valve surgery, Cardiac surgery, Diffusion Tensor Imaging, Brain Morphometry, 1H-Magnetic Resonance Spectroscopy
Medical subject headings
Postoperative Cognitive Complications, Cognitive Dysfunction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain MRI microstructural/functional alteration due to cardiac surgery in association with POCD

    On the basis of scientific literature, the patients during the first post-cardiosurgical week can show cognitive dysfunction in 40-70% of the cases, decreasing after 6 weeks to 10-40%, remaining stable over the long-term. To identify corresponding brain specific microstructural variations, simultaneously to the neuropsychological evaluation, the same group of patients will undergo to MRI with standard sequence and advanced morpho-structural methods (DTI and VBM). Comparing data with a group of healthy age-matched subjects (20), quantitative measurements by VBM and DTI will be carried out to identify GM and WM variations, subsequently correlated with onset of POCD.

    Measured: 32 months

  2. Brain MRI metabolic alteration due to cardiac surgery in association with POCD

    To explore pre- and post- operative metabolic changes on the brain using in-vivo proton magnetic resonance spectroscopy (1H-MRS) after otherwise successful cardiac surgery with no major neurological event.

    Measured: 32 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2012 (estimated)
  2. Study startOct 2013
  3. Primary completionJul 2016 (estimated)
  4. Study completionOct 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01622452
Sponsor's protocol ID
396/12 FTGM
Acronym
CardChNeuroMRI
Status last verified
Aug 2013
First submitted
15 Jun 2012
Last updated
15 Aug 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Cognitive Dysfunction, run by Fondazione Toscana Gabriele Monasterio.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Domenico Montanaro, MD (+390585493564, domenico.montanaro@ftgm.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain MRI microstructural/functional alteration due to cardiac surgery in association with POCD (time frame: 32 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in